GCS-11 is an effective activator of natural killer T (NKT) cells. It specifically promotes the production of IFN-gamma and IL-4, with a particular selectivity for IFN-gamma. As a compound, GCS-11 exhibits anticancer activity and holds potential as a promising adjuvant in cancer immunotherapy or vaccine development.
Target:
Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted
